Breast cancer: Oral SERDs in ER+ BC. Part 2 - Treatment selection and beyond
In this podcast, the experts deep-dive into two patient case studies of ER+/HER2- metastatic breast cancer, discussing the intricacies of treatment selection and sequencing to maximise outcomes, curre...
6 Des 202325min
Gastric and GEJ cancers: Clinical case discussions. Part 2 - metastatic disease
This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals NHS Foundation Trust, UK) di...
6 Des 202316min
Gastric and GEJ cancers: Clinical case discussions. Part 1 - non-metastatic disease
This podcast series consists of two episodes where expert oncologists Dr Sam Klempner (Massachusetts General Hospital, USA) and Dr Lizzy Smyth (Oxford University Hospitals NHS Foundation Trust, UK) di...
6 Des 202327min
Breast cancer: Oral SERDs in ER+ BC. Part 1 - Efficacy, safety and the treatment landscape
In this podcast, the experts give an overview of the EMERALD trial and present elacestrant as the first, and currently only, oral SERD to be FDA approved. They focus on the efficacy results and land...
6 Des 202323min
Prostate cancer: Treatment intensification in mCSPC - The nurse perspective
In this podcast GU NURSES CONNECT members Brenda Martone and Jennifer Sutton discuss the nurse role in managing treatment intensification for metastatic castration sensitive prostate cancer(mCSPC) pat...
6 Des 202319min
Colorectal cancer: Treatment sequencing in advanced mCRC
This podcast episode discusses treatment sequencing in advanced metastatic colorectal cancer (mCRC) patients, third line and beyond. Dr Shubham Pant from MD Anderson Cancer Center, Houston Texas USA ...
6 Des 202321min
Prostate cancer: Which mCSPC patients benefit from early treatment intensification? Case-based discussion
Assoc. Prof. Shilpa Gupta and Dr Fabio Schutz, discuss early treatment intensification with triplet therapy for metastatic castration-sensitive prostate cancer (mCSPC) in this GU CONNECT podcast. The ...
6 Des 202322min
Prostate cancer: PARP inhibitors. Part 3 - Efficacy and safety of combination therapy
Dr Tanya Dorff, a Medical Oncologist from the City of Hope Comprehensive Cancer Center and Dr Neeraj Agarwal, Medical Oncologist and Director of the Genitourinary Oncology Program at the Huntsman Canc...
6 Des 202322min
